Icu Medical (DE:IC7)

ICU Medical Stock Price & Analysis


IC7 Stock Chart & Stats

Day’s Range€0 - €0
52-Week Range― - ―
Previous Close€153
Average Volume (3M)N/A
Market CapN/A
Enterprise ValueN/A
Total Cash (Recent Filing)€268.89M
Total Debt (Recent Filing)€44.49M
P/E RatioN/A
Next EarningsNov 02, 2022
Next Dividend Ex-DateN/A
Dividend YieldN/A
Shares Outstanding23,899,381
Standard DeviationN/A
10 Day Avg. Volume0
30 Day Avg. VolumeN/A
P/B Ratio-8.89
P/S Ratio2.05
P/CF Ratio35.70
P/FCF Ratio-2.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/EbitdaN/A
Price Target Upside40.49% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering2



P/E Ratio Range

The price to earnings ratio. This is used by investors to assess a stock’s market price relative to its earnings.



What was ICU Medical’s price range in the past 12 months?
Currently, no data Available
What is ICU Medical’s market cap?
Currently, no data Available
When is ICU Medical’s upcoming earnings report date?
ICU Medical’s upcoming earnings report date is Nov 02, 2022 which is in 37 days.
    How were ICU Medical’s earnings last quarter?
    ICU Medical released its earnings results on Aug 08, 2022. The company reported €1.419 earnings per share for the quarter, missing the consensus estimate of €1.72 by -€0.3.
      Is ICU Medical overvalued?
      According to Wall Street analysts ICU Medical’s price is currently Undervalued. Get more investment ideas with TipRanks Premium
        Does ICU Medical pay dividends?
        ICU Medical does not currently pay dividends.
        What is ICU Medical’s EPS estimate?
        ICU Medical’s EPS estimate is €1.52.
          How many shares outstanding does ICU Medical have?
          Currently, no data Available
          What happened to ICU Medical’s price movement after its last earnings report?
          ICU Medical reported an EPS of €1.419 in its last earnings report, missing expectations of €1.72. Following the earnings report the stock price went up 4.545%.
            Which hedge fund is a major shareholder of ICU Medical?
            Among the largest hedge funds holding ICU Medical’s share is Fisher Asset Management LLC. It holds ICU Medical’s shares valued at 6M.


              ICU Medical Stock Analysis

              Smart ScoreUnderperform
              The ICU Medical Holdings stock analysis is based on the TipRanks Smart Score which is derived from 6 unique data sets including Analyst recommendations, Media Sentiment and multiple Technical stock factors. The Smart Score is a quantitative, data-driven rating system and does not include human intervention.
              Learn more about TipRanks Smart Score

              Company Description

              Icu Medical

              ICU Medical, Inc. is an infusion therapy company, which engages in the development, manufacturing and sale of innovative medical devices used in vascular therapy and critical care applications. The company's product portfolio includes intravenous smart pumps, sets, connectors, closed transfer devices for hazardous drugs, cardiac monitoring systems, IV solutions, IV smart pumps with pain management and safety software technology, dedicated and non-dedicated IV sets and needle-free connectors designed to help meet clinical, safety and workflow goals. Its customers are acute care hospitals, wholesalers, ambulatory clinics and alternate site facilities, such as clinics, home health care providers and long-term care facilities. The company was founded by George A. Lopez in 1984 and is headquartered in San Clemente, CA.

              Similar Stocks
              Price & Change
              Align Tech
              Cooper Co
              DENTSPLY SIRONA
              Staar Surgical

              Popular Stocks

              What's Included in PREMIUM?
              Make informed decisions based on Top Analysts' activity
              Know what industry insiders are buying
              Get actionable alerts from top Wall Street Analysts
              Find out before anyone else which stock is going to shoot up
              Get powerful stock screeners & detailed portfolio analysis